Stockreport

Aldeyra commences late-stage study of reproxalap in rare inherited skin disorder [Seeking Alpha]

Aldeyra Therapeutics, Inc.  (ALDX) 
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aldeyra.com/investor-relations
PDF Aldeyra commences late-stage study of reproxalap in rare inherited skin disorderEnrollment is underway in a Phase 3 clinical trial evaluating Aldeyra Therapeutics' (ALDX [Read more]